Clinical predictors of adverse cardiovascular events for acute pediatric drug exposures

On Behalf Of The Acmt Toxicology Investigators Consortium (Toxic)

Research output: Contribution to journalArticle

Abstract

Context: Risk factors for adverse cardiovascular events (ACVE) from drug exposures have been well-characterized in adults but not studied in children. The objective of the present study is to describe the incidence, characteristics, and risk factors for in-hospital ACVEs among pediatric emergency department (ED) patients with acute drug exposures. Methods: This is a prospective cohort design evaluating patients in the Toxicology Investigators Consortium (ToxIC) Registry. Pediatric patients (age <18 years) who were evaluated at the bedside by a medical toxicologist for a suspected acute drug exposure were included. The primary outcome was in-hospital ACVE (myocardial injury, shock, ventricular dysrhythmia, or cardiac arrest). The secondary outcome was in-hospital death. Multiple logistic regression analyses were performed to examine novel clinical risk factors and extrapolate adult risk factors (bicarbonate <20 mEq/L; QTc ≥500 ms), for the primary/secondary outcomes. Results: Among the 13,097 patients (58.5% female), there were 278 in-hospital ACVEs (2.1%) and 39 in-hospital deaths (0.3%). Age and drug class of exposure (specifically opioids and cardiovascular drugs) were independently associated with ACVE. Compared with adolescents, children under 2 years old (OR: 0.41, 95% CI: 0.21–0.80), ages 2–6 (OR: 0.37, 95% CI: 0.21–0.80), and ages 7–12 (OR: 0.51, 95% CI: 0.27–0.95) were significantly less likely to experience an ACVE. Serum bicarbonate concentration <20 mEq/L (OR: 2.31, 95% CI: 1.48–3.60) and QTc ≥ 500 ms (OR: 2.83, 95% CI: 1.67–4.79) were independently associated with ACVE. Conclusion: Previously derived clinical predictors of ACVE from an adult drug overdose population were successfully extrapolated to this pediatric population. Novel associations with ACVE and death included adolescent age and opioid drug exposures. In the midst of the opioid crisis, these findings urgently warrant further investigation to combat adolescent opioid overdose morbidity and mortality.

Original languageEnglish (US)
JournalClinical Toxicology
DOIs
StatePublished - Jan 1 2019

Fingerprint

Pediatrics
Opioid Analgesics
Cardiovascular Agents
Pharmaceutical Preparations
Bicarbonates
Drug Overdose
Heart Arrest
Toxicology
Population
Registries
Logistics
Hospital Emergency Service
Shock
Logistic Models
Regression Analysis
Research Personnel
Morbidity
Mortality
Incidence
Wounds and Injuries

Keywords

  • adverse events
  • cardiovascular
  • opioid
  • Pediatrics
  • poisoning

ASJC Scopus subject areas

  • Toxicology

Cite this

Clinical predictors of adverse cardiovascular events for acute pediatric drug exposures. / On Behalf Of The Acmt Toxicology Investigators Consortium (Toxic).

In: Clinical Toxicology, 01.01.2019.

Research output: Contribution to journalArticle

On Behalf Of The Acmt Toxicology Investigators Consortium (Toxic). / Clinical predictors of adverse cardiovascular events for acute pediatric drug exposures. In: Clinical Toxicology. 2019.
@article{baf5864107c1425e90ec0fb6dd202201,
title = "Clinical predictors of adverse cardiovascular events for acute pediatric drug exposures",
abstract = "Context: Risk factors for adverse cardiovascular events (ACVE) from drug exposures have been well-characterized in adults but not studied in children. The objective of the present study is to describe the incidence, characteristics, and risk factors for in-hospital ACVEs among pediatric emergency department (ED) patients with acute drug exposures. Methods: This is a prospective cohort design evaluating patients in the Toxicology Investigators Consortium (ToxIC) Registry. Pediatric patients (age <18 years) who were evaluated at the bedside by a medical toxicologist for a suspected acute drug exposure were included. The primary outcome was in-hospital ACVE (myocardial injury, shock, ventricular dysrhythmia, or cardiac arrest). The secondary outcome was in-hospital death. Multiple logistic regression analyses were performed to examine novel clinical risk factors and extrapolate adult risk factors (bicarbonate <20 mEq/L; QTc ≥500 ms), for the primary/secondary outcomes. Results: Among the 13,097 patients (58.5{\%} female), there were 278 in-hospital ACVEs (2.1{\%}) and 39 in-hospital deaths (0.3{\%}). Age and drug class of exposure (specifically opioids and cardiovascular drugs) were independently associated with ACVE. Compared with adolescents, children under 2 years old (OR: 0.41, 95{\%} CI: 0.21–0.80), ages 2–6 (OR: 0.37, 95{\%} CI: 0.21–0.80), and ages 7–12 (OR: 0.51, 95{\%} CI: 0.27–0.95) were significantly less likely to experience an ACVE. Serum bicarbonate concentration <20 mEq/L (OR: 2.31, 95{\%} CI: 1.48–3.60) and QTc ≥ 500 ms (OR: 2.83, 95{\%} CI: 1.67–4.79) were independently associated with ACVE. Conclusion: Previously derived clinical predictors of ACVE from an adult drug overdose population were successfully extrapolated to this pediatric population. Novel associations with ACVE and death included adolescent age and opioid drug exposures. In the midst of the opioid crisis, these findings urgently warrant further investigation to combat adolescent opioid overdose morbidity and mortality.",
keywords = "adverse events, cardiovascular, opioid, Pediatrics, poisoning",
author = "{On Behalf Of The Acmt Toxicology Investigators Consortium (Toxic)} and Stephanie Carreiro and Simone Miller and Bo Wang and Wax, {Paul M} and Sharan Campleman and Manini, {Alex F.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/15563650.2019.1634272",
language = "English (US)",
journal = "Clinical Toxicology",
issn = "1556-3650",
publisher = "Dekker",

}

TY - JOUR

T1 - Clinical predictors of adverse cardiovascular events for acute pediatric drug exposures

AU - On Behalf Of The Acmt Toxicology Investigators Consortium (Toxic)

AU - Carreiro, Stephanie

AU - Miller, Simone

AU - Wang, Bo

AU - Wax, Paul M

AU - Campleman, Sharan

AU - Manini, Alex F.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Context: Risk factors for adverse cardiovascular events (ACVE) from drug exposures have been well-characterized in adults but not studied in children. The objective of the present study is to describe the incidence, characteristics, and risk factors for in-hospital ACVEs among pediatric emergency department (ED) patients with acute drug exposures. Methods: This is a prospective cohort design evaluating patients in the Toxicology Investigators Consortium (ToxIC) Registry. Pediatric patients (age <18 years) who were evaluated at the bedside by a medical toxicologist for a suspected acute drug exposure were included. The primary outcome was in-hospital ACVE (myocardial injury, shock, ventricular dysrhythmia, or cardiac arrest). The secondary outcome was in-hospital death. Multiple logistic regression analyses were performed to examine novel clinical risk factors and extrapolate adult risk factors (bicarbonate <20 mEq/L; QTc ≥500 ms), for the primary/secondary outcomes. Results: Among the 13,097 patients (58.5% female), there were 278 in-hospital ACVEs (2.1%) and 39 in-hospital deaths (0.3%). Age and drug class of exposure (specifically opioids and cardiovascular drugs) were independently associated with ACVE. Compared with adolescents, children under 2 years old (OR: 0.41, 95% CI: 0.21–0.80), ages 2–6 (OR: 0.37, 95% CI: 0.21–0.80), and ages 7–12 (OR: 0.51, 95% CI: 0.27–0.95) were significantly less likely to experience an ACVE. Serum bicarbonate concentration <20 mEq/L (OR: 2.31, 95% CI: 1.48–3.60) and QTc ≥ 500 ms (OR: 2.83, 95% CI: 1.67–4.79) were independently associated with ACVE. Conclusion: Previously derived clinical predictors of ACVE from an adult drug overdose population were successfully extrapolated to this pediatric population. Novel associations with ACVE and death included adolescent age and opioid drug exposures. In the midst of the opioid crisis, these findings urgently warrant further investigation to combat adolescent opioid overdose morbidity and mortality.

AB - Context: Risk factors for adverse cardiovascular events (ACVE) from drug exposures have been well-characterized in adults but not studied in children. The objective of the present study is to describe the incidence, characteristics, and risk factors for in-hospital ACVEs among pediatric emergency department (ED) patients with acute drug exposures. Methods: This is a prospective cohort design evaluating patients in the Toxicology Investigators Consortium (ToxIC) Registry. Pediatric patients (age <18 years) who were evaluated at the bedside by a medical toxicologist for a suspected acute drug exposure were included. The primary outcome was in-hospital ACVE (myocardial injury, shock, ventricular dysrhythmia, or cardiac arrest). The secondary outcome was in-hospital death. Multiple logistic regression analyses were performed to examine novel clinical risk factors and extrapolate adult risk factors (bicarbonate <20 mEq/L; QTc ≥500 ms), for the primary/secondary outcomes. Results: Among the 13,097 patients (58.5% female), there were 278 in-hospital ACVEs (2.1%) and 39 in-hospital deaths (0.3%). Age and drug class of exposure (specifically opioids and cardiovascular drugs) were independently associated with ACVE. Compared with adolescents, children under 2 years old (OR: 0.41, 95% CI: 0.21–0.80), ages 2–6 (OR: 0.37, 95% CI: 0.21–0.80), and ages 7–12 (OR: 0.51, 95% CI: 0.27–0.95) were significantly less likely to experience an ACVE. Serum bicarbonate concentration <20 mEq/L (OR: 2.31, 95% CI: 1.48–3.60) and QTc ≥ 500 ms (OR: 2.83, 95% CI: 1.67–4.79) were independently associated with ACVE. Conclusion: Previously derived clinical predictors of ACVE from an adult drug overdose population were successfully extrapolated to this pediatric population. Novel associations with ACVE and death included adolescent age and opioid drug exposures. In the midst of the opioid crisis, these findings urgently warrant further investigation to combat adolescent opioid overdose morbidity and mortality.

KW - adverse events

KW - cardiovascular

KW - opioid

KW - Pediatrics

KW - poisoning

UR - http://www.scopus.com/inward/record.url?scp=85068838418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068838418&partnerID=8YFLogxK

U2 - 10.1080/15563650.2019.1634272

DO - 10.1080/15563650.2019.1634272

M3 - Article

C2 - 31267804

AN - SCOPUS:85068838418

JO - Clinical Toxicology

JF - Clinical Toxicology

SN - 1556-3650

ER -